NEW YORK (360Dx) – First Light Biosciences on Thursday said that the US Department of Health and Human Services' Biomedical Advanced Research and Development Authority has approved a two-year, $10.7 million extension of a multiyear contract to develop its automated MultiPath Platform, which uses digital imaging and rapid tests to detect urinary tract infections and anthrax poisoning.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.